Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials

Matteo Lambertini, Samuel Martel, Christine Campbell, Sébastien Guillaume, Florentine S. Hilbers, Uwe Schuehly, Larissa Korde, Hatem A. Azim, Serena Di Cosimo, Richard C. Tenglin, Jens Huober, José Baselga, Alvaro Moreno-Aspitia, Martine Piccart-Gebhart, Richard D. Gelber, Evandro de Azambuja, Michail Ignatiadis

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials'. Together they form a unique fingerprint.

Medicine & Life Sciences